molecular
dock
studi
perform
sever
structur
divers
ar
antagonist
includ
xanthin
nonxanthin
type
antagonist
investig
bind
mode
adenosin
receptor
ar
one
four
subtyp
ar
current
great
interest
target
therapeut
intervent
particular
parkinson
diseas
highaffin
bind
site
found
hydrophob
pocket
involv
hydrogen
bond
interact
well
pp
stack
interact
ligand
detail
bind
mode
xanthin
nonxanthin
type
antagonist
compar
essenti
featur
extract
convert
databas
searchabl
queri
virtual
screen
studi
novel
ar
antagonist
find
studi
help
elucid
bind
pattern
ar
antagonist
design
novel
activ
ligand
adenosin
receptor
ar
belong
superfamili
seven
transmembran
domain
g
proteincoupl
receptor
four
subtyp
receptor
clone
character
fredholm
et
al
ar
found
wide
varieti
tissu
presid
panopli
biolog
effect
known
receptor
activ
adenyl
cyclas
receptor
caus
revers
effect
hourani
et
al
result
ligand
receptor
desir
pharmacolog
medicin
studi
particular
treatment
seriou
disord
hypoxia
asthma
parkinson
diseas
stimul
ar
recent
found
reduc
bind
affin
dopamin
receptor
ongini
et
al
richardson
et
al
particip
inhibit
tumor
necrosi
factora
elenkov
et
al
addit
ar
abnorm
increas
cell
express
mutant
huntingtin
varani
et
al
therefor
ar
antagonist
becom
great
interest
therapeut
intervent
particular
treatment
parkinson
diseas
last
decad
mani
ar
antagonist
includ
xanthin
nonxanthin
deriv
propos
major
seri
ar
antagonist
xanthin
antagonist
suffer
low
select
poor
pharmacophysiolog
properti
nonaka
et
al
u
uller
et
al
sauer
et
al
xanthin
type
adenosin
antagonist
theophyllin
close
relat
analog
caffein
use
clinic
antiasthmat
agent
base
weak
adenosin
antagonist
activ
feokistov
biaggioni
usag
associ
unpleas
side
effect
insomnia
diuresi
vassalo
lipski
overcom
abovement
shortcom
nonxanthin
type
heterocycl
antagonist
later
develop
demonstr
recent
two
main
class
bicycl
tricycl
nonxanthin
deriv
barbara
et
al
vu
et
al
b
matasi
et
al
encourag
result
especi
increas
select
nonxanthin
type
analog
stimul
interest
scientist
develop
structur
divers
antagonist
use
therapeut
agent
seven
ar
transmembran
domain
connect
three
extracellular
three
intracellular
hydrophil
loop
bockaert
pin
given
macromolecul
could
easili
crystal
structur
elucid
via
xray
crystallographi
structur
model
adenosin
receptor
includ
ar
construct
use
homolog
model
method
base
structur
bovin
rhodopsin
whose
data
xray
diffract
publish
late
ivanov
et
al
ivanov
et
al
ivanov
et
al
stefano
et
al
recent
studi
pharmacophor
model
select
ar
antagonist
demonstr
ligandbas
approach
use
analyz
ligandreceptor
interact
howev
systemat
receptorbas
dock
studi
report
field
especi
use
nonxanthin
type
ar
antagonist
aim
present
work
use
molecular
model
character
bind
mode
differ
type
ar
antagonist
particular
differenti
xanthin
type
antagonist
nonxanthin
deriv
dock
process
studi
use
comput
tool
design
novel
select
ar
antagonist
result
bind
mode
analysi
pharmacophor
observ
may
also
use
molecular
surfac
colorcod
hydrophob
properti
green
hydrophob
blue
hydrophil
constitu
pocket
defin
residu
within
distanc
ligand
better
illustr
bind
mode
residu
one
side
pocket
hidden
interpret
refer
colour
figur
reader
refer
onlin
version
paper
wwwspringerlinkcom
ration
drug
discoveri
integr
molecular
dock
process
virtual
screen
ar
antagonist
molecular
dock
techniqu
provid
mani
use
clue
insight
drug
design
chou
et
al
chou
du
et
al
du
et
al
du
et
al
siroi
et
al
wei
et
al
wei
et
al
wei
et
al
b
zhang
et
al
gui
et
al
wang
et
al
c
studi
seven
structur
divers
ar
antagonist
fig
includ
highli
select
nonxanthin
type
ar
antagonist
chosen
train
set
dock
studi
ar
antagonist
model
within
viewcompound
workbench
use
catalyst
optim
forc
field
use
chimera
compound
dock
use
activ
bind
site
adenosin
receptor
whose
structur
data
recent
releas
rcsb
protein
data
bank
pdb
entri
graphic
manipul
visual
perform
mean
chimera
program
ligand
dock
perform
use
dock
gener
databas
searchabl
pharmacophor
execut
use
catalyst
instal
work
station
equip
aintel
xeon
processor
ghz
ram
run
redhat
oper
system
accord
chou
et
al
bind
pocket
defin
residu
least
one
heavi
atom
ie
atom
hydrogen
distanc
heavi
atom
ligand
definit
wide
success
use
investig
variou
proteinligand
interact
chou
et
al
chou
b
c
siroi
et
al
chou
b
du
et
al
b
wei
et
al
wei
et
al
b
zhang
et
al
gao
et
al
li
et
al
wang
et
al
b
work
dock
program
identifi
activ
bind
pocket
ar
antagonist
surround
five
transmembran
helic
find
consist
result
sitedirect
mutagenesi
studi
kim
et
al
order
determin
residu
involv
stabl
bind
interact
antagonist
ar
first
perform
molecular
dock
studi
use
three
potent
xanthin
type
antagonist
baraldi
et
al
accord
result
antagonist
activ
studi
e
isom
substitut
xanthin
type
antagonist
potent
z
isom
focus
dock
analysi
energi
score
e
configur
styryl
side
chain
outcom
dock
analysi
indic
three
xanthin
type
antagonist
similar
bind
mode
pattern
fig
interact
pattern
obtain
clinic
candid
parkinson
diseas
knutsen
weiss
suggest
side
chain
phenyl
ring
molecul
point
cell
surfac
xanthin
moieti
occupi
bottom
bind
pocket
bind
mode
illustr
fig
hydroxyl
group
form
hydrogen
bond
carbonyl
oxygen
xanthin
moieti
addit
anoth
weak
hydrogen
bond
interact
nh
group
oxygen
may
also
contribut
affin
ligand
receptor
hydrophob
pocket
delimit
interact
ethyl
substitu
xanthin
moieti
amino
acid
shown
fig
along
abovement
residu
constitut
bottom
bind
pocket
accommod
whole
xanthin
moieti
ligand
addit
interact
imidazol
ring
xanthin
structur
pp
interact
result
good
agreement
mutagenet
studi
chang
ala
lead
loss
antagon
wherea
replac
phe
tyr
effect
antagonist
bind
affin
kim
et
al
phenyl
ring
highli
potent
antagonist
two
methoxi
group
locat
entranc
bind
pocket
larg
occupi
hydrophob
residu
weak
pp
stack
interact
phenyl
group
also
predict
bind
mode
virtual
xanthin
moieti
two
ligand
resid
similar
posit
wherea
aromat
group
side
chain
fall
hydrophob
pocket
interact
correspond
residu
howev
involv
ligand
bind
via
strong
pp
interact
phenyl
moieti
data
obtain
bsdmpx
highli
select
xanthin
type
antagonist
suggest
arrang
phenyl
group
ligand
similar
singl
metasubstitu
involv
hydrophob
interact
pocket
surfac
phenyl
ring
within
strong
pp
interact
distanc
substitu
unlik
two
ligand
xanthin
moieti
ligand
flip
orient
bind
pocket
accord
dock
result
molecul
one
hydrogen
bond
interact
observ
carbonyl
oxygen
xanthin
moieti
signific
interact
found
carbonyl
group
propargyl
group
xanthin
core
occupi
cyan
compound
yellow
compound
red
dock
bind
pocket
molecular
surfac
colorcod
hydrophob
properti
green
hydrophob
blue
hydrophil
constitu
pocket
defin
residu
within
distanc
ligand
better
illustr
bind
mode
residu
one
side
pocket
hidden
interpret
refer
colour
figur
reader
refer
onlin
version
paper
wwwspringerlinkcom
hydrophob
site
surround
opposit
site
taken
two
compound
due
flip
xanthin
plane
dock
studi
nonxanthin
type
ar
antagonist
first
evalu
compound
strong
bind
affin
ki
nm
high
select
ki
ki
ki
ki
ki
ki
barbara
et
al
bind
model
dock
analysi
suggest
small
furan
ring
embed
deepli
bottom
bind
pocket
delimit
fig
fig
wherea
xanthin
type
antagonist
prohibit
deep
interposit
extent
due
structur
bulki
xanthin
group
hydrogen
bond
oxygen
furan
moieti
hydroxyl
group
predict
import
interact
within
pocket
pyrazol
ring
tricycl
structur
predict
involv
pp
interact
wherea
anoth
pp
stack
interact
central
pyrimidin
ring
also
regard
import
molecular
bind
result
line
find
mutagenet
studi
kim
et
al
anilin
moieti
side
chain
point
extracellular
environ
interact
hydrophob
surfac
shape
entranc
bind
pocket
bind
pattern
compound
show
arrang
tricycl
moieti
ligand
similar
compound
addit
hydrogen
bond
interact
n
atom
tricycl
structur
also
involv
ligand
bind
howev
due
signific
differ
side
chain
two
compound
phenyl
ring
compound
lie
differ
hydrophob
surfac
surround
ethyl
group
ester
moieti
interact
hydrophob
residu
illustr
fig
nonxanthin
antagonist
compound
present
similar
bind
mode
bicycl
moieti
tricycl
deriv
howev
furan
ring
lie
new
pocket
delimit
thu
lose
hydrogen
bond
weak
hydrogen
bond
interact
observ
bridg
n
atom
piperazin
structur
quinolin
moieti
end
side
chain
form
strong
interact
hydrophob
surfac
shape
differ
compound
side
chain
aromat
ring
moieti
therefor
similar
bind
mode
observ
compound
increas
magnitud
pp
interact
triazin
ring
combin
dock
result
discuss
xanthin
nonxanthin
type
ar
antagonist
abl
extract
bind
mode
featur
could
essenti
differ
ligand
potenti
ar
antagonist
convert
databas
searchabl
pharmacophor
model
figur
illustr
two
exampl
pharmacophor
model
xanthin
fig
nonxanthin
antagonist
fig
share
similar
pp
interact
antagonist
correspond
aromat
residu
addit
least
two
hydrophob
interact
zone
end
molecul
hydrogen
bond
interact
type
antagonist
may
also
play
import
role
bind
antagonist
recognit
final
order
integr
dock
studi
routin
drug
design
screen
process
provid
rapid
evalu
bind
affin
virtual
librari
potenti
antagonist
calcul
solventfre
lowest
bind
energi
antagonistreceptor
complex
use
energi
score
function
implement
dock
program
tabl
total
interact
energi
consist
van
der
waal
electrostat
compon
three
xanthin
type
antagonist
bsdmpx
substanti
level
reflect
similar
ki
valu
antagonist
bind
energi
score
nonxanthin
type
ar
antagonist
rang
kcalmol
also
indic
similar
interact
level
ligand
strong
receptor
bind
affin
ki
nm
structurebas
dock
analysi
databas
searchabl
pharmacophor
retriev
bind
mode
studi
consid
combin
strategi
increas
accuraci
well
effici
virtual
screen
process
novel
ar
antagonist
fig
pharmacophorebas
screen
step
act
filter
system
commercialinhous
compound
librari
virtual
design
target
focus
librari
pharmacophor
deriv
xanthin
type
antagonist
first
remov
exist
xanthin
caffein
deriv
pick
structur
novel
compound
potenti
antagonist
wherea
nonxanthin
type
antagonist
deriv
pharmacophor
model
may
directli
function
probe
identifi
new
substrat
potenti
antagonist
ligand
primari
hit
pharmacophorebas
screen
analysi
evalu
dock
studi
effici
identifi
true
posit
pharmacophorebas
screen
step
structurebas
dock
analysi
integr
score
function
catalyst
best
fit
valu
calcul
fit
score
make
combin
approach
conveni
practic
tool
applic
virtual
screen
project
base
result
molecular
dock
studi
propos
gener
bind
mode
select
ar
antagonist
defin
residu
involv
receptorligand
recognit
xanthin
type
antagonist
model
demonstr
could
essenti
hydrogen
bond
format
carbonyl
group
ligand
could
involv
stabl
ligand
bind
pp
interact
antagonist
moreov
hydrophob
interact
domain
locat
entranc
bottom
bind
pocket
suppos
make
import
contribut
bind
affin
ar
antagonist
class
nonxanthin
ligand
two
adjac
hydrophob
site
one
delimit
residu
residu
accommod
furan
moieti
along
hydrophob
pocket
interact
side
chain
support
basic
bind
ligand
weak
hydrogen
bond
interact
furan
oxygen
piperazin
nitrogen
may
contribut
bind
affin
pp
interact
residu
heterocycl
moieti
ligand
pro
base
extract
interact
mode
seri
databas
searchabl
pharmacophor
model
creat
repres
differ
combin
import
bind
interact
antagonist
pharmacophor
model
use
identifi
potenti
new
antagonist
propos
pharmacophorebas
virtual
screen
approach
molecular
dock
analysi
studi
use
either
structurebas
drug
design
tool
integr
pharmacophorebas
virtual
screen
approach
order
enhanc
accuraci
virtual
screen
improv
enrich
true
posit
